• DOI:10.1007/s00066-018-1269-3
Corpus ID: 3315984

Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy

@article{Ghadjar2018UseOA,
  title={Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy},
  author={P. Ghadjar and D. Aebersold and C. Albrecht and D. Boehmer and M. Flentje and U. Ganswindt and S. H{\"o}cht and T. H{\"o}lscher and F. Sedlmayer and F. Wenz and D. Zips and T. Wiegel and Prostate Cancer Expert Panel of the German Society of Radia Society},
  journal={Strahlentherapie und Onkologie},
  year={2018},
  volume={194},
  pages={619-626}
}

P. Ghadjar, D. Aebersold, +10 authors Prostate Cancer Expert Panel of the German Society of Radia Society

Published 2018

Medicine

Strahlentherapie und Onkologie

AimOverview on the use of androgen deprivation therapy (ADT) added to salvage radiation therapy (SRT) for prostate cancer patients with biochemical recurrence after prostatectomy.MethodsThe German Society of Radiation Oncology (DEGRO) expert panel summarized available evidence published between January 2009 and May 2017, and assessed the validity of the information on outcome parameters including overall survival (OS) and treatment-related toxicity.ResultsTwo randomized controlled trials and… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed